Indiana University Health and the Indiana University School of Medicine announced they will invest $150 million over 5 years in a new research collaboration, the Strategic Research Initiative, that will enhance the institutions’ joint capabilities in fundamental scientific investigation, translational research and clinical trials.

Each entity will invest $75 million in the Strategic Research Initiative. The initial focus will be on projects in the fields of neuroscience, cancer and cardiovascular disease.

The three target research areas are cancer, neuroscience, and cardiovascular health.

One of the initiative’s primary goals is to enable the Indiana University Melvin and Bren Simon Cancer Center to attain the National Cancer Institute’s top status of “comprehensive”. To support that goal the initiative will provide funds to recruit leading cancer researchers and expand cancer clinical trials in Indiana.

The neurosciences research program will tackle a broad range of brain injuries, neurodegenerative disorders and neurodevelopmental disorders.

The cardiovascular research initiative will focus on developing a cardiovascular genetics program and recruiting a top scientist in that field.